Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Laboratorios Biopas

Latest From Laboratorios Biopas

Deal Watch: Merck KGaA Enhances Cell/Gene Therapy Capabilities With Mirus Takeout

Plus deals involving Immunis/Toray, AstraZeneca/Nona, Swixx/Biopas, Deimos/G1, Serum Institute of India/IntegriMedical/ImmunityBio plus tech transfer agreements and deals in brief.

Deal Watch Business Strategies

Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals

South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.

BioPharmaceutical South Korea
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Biopas Laboratoires